Purchase Order 75F40124P00529

Award Date 9/29/24
Potential Completion Date 9/29/27
Potential Value $190K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a division of Danaher Corporation, for preventative maintenance and unlimited repair services on a Molecular Devices ImageXpress Micro Confocal (IXMC) High Content Imaging System. The contract has a base period of one year and four one-year option periods, with a ceiling value of $219,315.88 if all options are exercised. The contract was competitively awarded, with no...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for the provision of a microplate reader and accessories with a ceiling value of $23,350.77. The contract has an ultimate completion date of November 14, 2014. Molecular Devices LLC is a for-profit limited liability company that specializes in advanced bioanalytical measurement solutions and has a strong presence in...
This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency of the U.S. government, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $10,217.00 contract is for a maintenance agreement covering Molecular Devices' specialized bioanalytical instrumentation, software, and related services used in life sciences research, pharmaceutical development, and public health initiatives. As the original equipment manufacturer, Molecular...
This is a $10,217 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation. The contract is for a service agreement with an ultimate completion date of August 8, 2025. Molecular Devices is a leading provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development. The company often receives sole-source awards as the original...
This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Molecular Devices LLC, a division of Danaher Corporation, for maintenance services for an image processing system. The contract has a ceiling value of $17,807.00 and a completion date of July 31, 2023. Molecular Devices LLC is the original equipment manufacturer and a frequent provider of bioanalytical instruments, equipment, and related services to various federal agencies, including the...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation, for onsite performance assurance and one-time preventative maintenance service for the agency's Molecular Devices instruments. The contract has a ceiling value of $14,555.00 and an ultimate completion date of October 17, 2025. Molecular Devices LLC is a leading provider of bioanalytical...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the U.S. Department of Health and Human Services. The $57,545.00 contract is for a service agreement to provide laboratory equipment from Molecular Devices LLC, a division of Danaher Corporation. The contract does not have a set-aside designation and has an ultimate completion date of October 31, 2023. Molecular Devices LLC, as the...
This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Molecular Devices LLC, a division of Danaher Corporation, for the maintenance of laboratory equipment. The contract has a ceiling value of $14,771.70 and a completion date of February 10, 2024. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions for life science research, pharmaceutical, and biotherapeutic development, and this contract is for...
This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a division of Danaher Corporation, to procure a SpectraMax iD3 multi-mode microplate reader. The $24,994.92 contract will replace an existing, non-functioning instrument due to software/operating system incompatibilities. Molecular Devices is a leading provider of bioanalytical measurement solutions and has received numerous prime federal contracts from agencies like the NIH,...
This is a firm fixed-price purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Molecular Devices LLC, a subsidiary of Danaher Corporation. The $142,155.00 contract is for on-site performance assurance services for a FLIPR TETRA 96/384 molecular device system. The contract has an ultimate completion date of February 25, 2024 and was awarded on February 26, 2021. No set-aside was used for this award. Molecular Devices is a...

This is a $190,019.00 firm fixed-price purchase order awarded by the U.S. Food and Drug Administration (FDA) and Center for Food Safety and Applied Nutrition (CFSAN) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for an on-site preventative maintenance service agreement for Molecular Devices' Image-Xpress Confocal HT.AI high-content screening system. The contract has an ultimate completion date of September 29, 2027. Molecular Devices is a for-profit limited liability company that specializes in high-performance bioanalytical measurement solutions for life science research, pharmaceutical development, and biotherapeutic research. The company has a strong presence in federal government contracting, providing specialized scientific equipment, maintenance services, and technological solutions to agencies like the NIH, CDC, and VA. This contract is not set aside and represents Molecular Devices' continued support of federal scientific research infrastructure.

Generated 6/13/25, 9:53 AM